John N Wood Selected Research

Sodium

10/2017	Synergistic regulation of serotonin and opioid signaling contributes to pain insensitivity in Nav1.7 knockout mice.
11/2014	Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use.
12/2006	SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes.
1/2004	Ion channel activities implicated in pathological pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John N Wood Research Topics

Disease

80	Pain (Aches) 01/2024 - 01/2002
21	Neuralgia (Stump Neuralgia) 01/2022 - 08/2003
17	Hyperalgesia 12/2023 - 10/2002
10	Chronic Pain 01/2023 - 08/2008
9	Hypersensitivity (Allergy) 01/2023 - 06/2011
7	Neoplasms (Cancer) 01/2022 - 09/2012
7	Inflammation (Inflammations) 01/2018 - 02/2008
5	Channelopathies 11/2014 - 12/2006
4	Acute Pain 01/2023 - 11/2010
4	Visceral Pain 01/2020 - 06/2010
3	Cystitis 06/2017 - 10/2002
2	Cancer Pain 01/2023 - 01/2022
2	Congenital Pain Insensitivity 10/2022 - 12/2015
2	Anosmia 01/2021 - 04/2011
2	Ciguatera Poisoning (Ciguatera) 01/2021 - 10/2012
2	Bone Neoplasms (Bone Cancer) 11/2020 - 01/2018
2	Osteoarthritis 01/2018 - 01/2018
2	Myalgia 01/2018 - 06/2014
2	Nociceptive Pain 06/2017 - 01/2017
2	Erythromelalgia (Erythermalgia) 01/2015 - 06/2013
2	Migraine Disorders (Migraine) 09/2012 - 06/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024
1	Abdominal Pain (Pain, Abdominal) 01/2024
1	Crohn Disease (Crohn's Disease) 01/2024
1	Ulcerative Colitis 01/2024
1	Hereditary Sensory and Autonomic Neuropathies (HSAN) 12/2023
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Bone Resorption 01/2021
1	Colitis 01/2020

Drug/Important Bio-Agent (IBA)

25	Voltage-Gated Sodium ChannelsIBA 10/2022 - 10/2004
21	Sodium Channels (Sodium Channel)IBA 06/2017 - 01/2002
19	Analgesics (Analgesic Drugs)IBA 01/2024 - 01/2004
10	Formaldehyde (Formol)FDA Link 12/2023 - 08/2004
9	Ion Channels (Ion Channel)IBA 01/2020 - 01/2004
8	Nerve Growth Factor (NGF)IBA 12/2023 - 08/2004
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2008
6	Opioid Analgesics (Opioids)IBA 12/2023 - 06/2011
6	Freund's AdjuvantIBA 01/2018 - 08/2004
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 01/2014
5	CalciumIBA 01/2022 - 01/2004
5	Tetrodotoxin (Tetradotoxin)IBA 10/2017 - 06/2002
5	CarrageenanIBA 01/2017 - 08/2004
4	SodiumIBA 10/2017 - 01/2004
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 06/2010
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 10/2004
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018 - 03/2006
3	Capsaicin (Zostrix)FDA Link 06/2017 - 10/2002
3	Morphine (MS Contin)FDA LinkGeneric 06/2017 - 01/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2017 - 10/2002
3	Sodium Channel BlockersIBA 01/2016 - 10/2004
3	Lidocaine (Xylocaine)FDA LinkGeneric 09/2015 - 10/2004
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2010 - 01/2004
2	EnzymesIBA 01/2023 - 08/2008
2	CytokinesIBA 01/2021 - 05/2012
2	AcidsIBA 11/2020 - 06/2014
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2015
2	Eph Family Receptors (Eph Receptors)IBA 01/2020 - 11/2010
2	Ephrin-B2 (Ephrin B2)IBA 01/2020 - 11/2010
2	Conotoxins (Conotoxin)IBA 01/2018 - 10/2004
2	Opioid Receptors (Opioid Receptor)IBA 01/2018 - 06/2011
2	Opiate AlkaloidsIBA 01/2017 - 01/2013
2	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2017 - 01/2013
2	Tamoxifen FDA LinkGeneric 01/2016 - 11/2015
2	Pain-FreeIBA 01/2016 - 04/2012
2	Dinoprostone (PGE2)FDA Link 10/2014 - 09/2010
2	InterleukinsIBA 06/2014 - 05/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2012 - 02/2010
2	Potassium Channels (Potassium Channel)IBA 06/2010 - 01/2004
2	Calcium Channels (Calcium Channel)IBA 06/2010 - 08/2008
1	Angiotensin Receptor AntagonistsIBA 01/2024
1	Angiotensin IIIBA 01/2024
1	Valsartan (Vals)FDA Link 01/2024
1	RNA (Ribonucleic Acid)IBA 01/2024
1	Minocycline (Cyclops)FDA LinkGeneric 12/2023
1	LipopolysaccharidesIBA 12/2023
1	ParvalbuminsIBA 10/2023
1	PlatinumIBA 01/2023
1	anandamide (arachidonylethanolamide)IBA 01/2023
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2023
1	Varenicline (Chantix)FDA Link 01/2023
1	Pregabalin (Lyrica)FDA Link 01/2023
1	Cystine-Knot MiniproteinsIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Chloride Channels (Chloride Channel)IBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	EndocannabinoidsIBA 01/2023
1	Long Noncoding RNAIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	PurinesIBA 01/2022
1	IL4-IL10 fusion proteinIBA 01/2021
1	RANK LigandIBA 01/2021

Therapy/Procedure

8	Therapeutics 01/2023 - 11/2010
6	Analgesia 01/2023 - 06/2011
4	Ligation 01/2021 - 06/2011
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
2	Pain Management 01/2022 - 01/2021
1	Intravenous Injections 01/2023
1	Injections 01/2021
1	Spinal Injections 01/2021